These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8197767)

  • 1. Molecular biology of breast carcinoma.
    el-Ashry D; Lippman ME
    World J Surg; 1994; 18(1):12-20. PubMed ID: 8197767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility to ras oncogene transformation is coregulated with signal transduction through growth factor receptors.
    Chiao PJ; Kannan P; Yim SO; Krizman DB; Wu TA; Gallick GE; Tainsky MA
    Oncogene; 1991 May; 6(5):713-20. PubMed ID: 1646984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant function of the Ras signal transduction pathway in human breast cancer.
    Clark GJ; Der CJ
    Breast Cancer Res Treat; 1995 Jul; 35(1):133-44. PubMed ID: 7612899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.
    Archer SG; Eliopoulos A; Spandidos D; Barnes D; Ellis IO; Blamey RW; Nicholson RI; Robertson JF
    Br J Cancer; 1995 Nov; 72(5):1259-66. PubMed ID: 7577479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oncogenes and tumor suppressor genes in the signal transduction pathways of growth factors].
    Buday L
    Orv Hetil; 1994 Nov; 135(47):2579-84. PubMed ID: 7824256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor receptors in breast cancer.
    Wang S; Ding Z
    Tumour Biol; 2017 May; 39(5):1010428317698370. PubMed ID: 28459213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenes and antioncogenes in human breast carcinoma.
    Leslie KO; Howard P
    Pathol Annu; 1992; 27 Pt 1():321-42. PubMed ID: 1346552
    [No Abstract]   [Full Text] [Related]  

  • 8. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer.
    Datta D; Flaxenburg JA; Laxmanan S; Geehan C; Grimm M; Waaga-Gasser AM; Briscoe DM; Pal S
    Cancer Res; 2006 Oct; 66(19):9509-18. PubMed ID: 17018607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
    Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
    Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of ras Rb1 and p53 proteins in human breast cancer.
    Spandidos DA; Karaiossifidi H; Malliri A; Linardopoulos S; Vassilaros S; Tsikkinis A; Field JK
    Anticancer Res; 1992; 12(1):81-9. PubMed ID: 1567185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
    Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
    Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of EGFR and EGFR-downstream pathways in triple negative breast carcinomas with basal like features.
    Martin V; Botta F; Zanellato E; Molinari F; Crippa S; Mazzucchelli L; Frattini M
    Histol Histopathol; 2012 Jun; 27(6):785-92. PubMed ID: 22473698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenes and tumour suppressor genes in breast cancer.
    Eccles MR; Phipps RF
    Br J Hosp Med; 1993 Nov 3-16; 50(9):529-36. PubMed ID: 7904528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recapitulation of ras oncogene mutations in breast cancer.
    Stamatakos M; Stefanaki C; Kontzoglou K; Masouridi S; Sakorafas G; Safioleas M
    Onkologie; 2010; 33(10):540-4. PubMed ID: 20926903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor decreases CMYC and KRAS expression by upregulating let-7a expression in ER-, PR-, AR+ breast cancer.
    Lyu S; Yu Q; Ying G; Wang S; Wang Y; Zhang J; Niu Y
    Int J Oncol; 2014 Jan; 44(1):229-37. PubMed ID: 24172884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
    Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
    J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of key pathways and genes in mutant KRAS colorectal cancer by integrated bioinformatics analysis.
    Zhang H; Zhang X; Chen X; Zhang W; Xian J; Zhou X; Yang J; Wang J
    Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):615-617. PubMed ID: 29688256
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway.
    Clark JW; Santos-Moore A; Stevenson LE; Frackelton AR
    Int J Cancer; 1996 Jan; 65(2):186-91. PubMed ID: 8567115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biology of solid cancers: breast cancer as an example. Second part: gene disregulation in breast cancer].
    Bièche I; Lidereau R
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(2):142-52. PubMed ID: 8690862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers.
    Adnane J; Gaudray P; Dionne CA; Crumley G; Jaye M; Schlessinger J; Jeanteur P; Birnbaum D; Theillet C
    Oncogene; 1991 Apr; 6(4):659-63. PubMed ID: 1851551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.